Teva Pharmaceutical Industries reported $15.65B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Aspen Pharmacare ZAR 15.77B 1.73B Dec/2025
Cipla INR 70.14B 7.16B Mar/2026
Dr.Reddys Laboratories INR 157.34B 10.13B Jun/2026
Guangzhou Baiy CNY 38.98B 1.78B Jun/2026
Jiangsu Hengrui CNY 4.25B 1.39B Jun/2026
Kalbe Farma IDR 5.6T 925.49B Mar/2026
Richter Gedeon HUF 179.31B 8.13B Mar/2026
Sh Fosun Pharma CNY 38.6B 2.02B Jun/2026
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026